Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Glauconix Biosciences
company
About
Glauconix Biosciences specialist in pharmaceutical research company that uses technology to lower the cost of ophthalmic drug development.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $225K
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$2.13M
Glauconix Biosciences has raised a total of
$2.13M
in funding over 2 rounds. Their latest funding was raised on
May 1, 2017 from a Angel round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 1, 2017 | Angel | $250K | 1 |
Eastern New York Angels
|
— | Detail |
| Apr 4, 2017 | Grant | $1.40M | 1 |
National Science Foundation
|
— | Detail |
| Mar 23, 2015 | Angel | $250K | 1 |
Eastern New York Angels
|
— | Detail |
| Dec 18, 2014 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
4
2
Glauconix Biosciences is funded by 2 investors.
Eastern New York Angels
and National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Eastern New York Angels
|
Yes | Angel |
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
